These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3020325)

  • 61. Nitrous oxide analgesia: reversal by naloxone and development of tolerance.
    Berkowitz BA; Finck AD; Ngai SH
    J Pharmacol Exp Ther; 1977 Dec; 203(3):539-47. PubMed ID: 925957
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of intracerebral microinjection of naloxone on acupuncture- and morphine-analgesia in the rabbit.
    Zhou ZF; Du MY; Wu WY; Jiang Y; Han JS
    Sci Sin; 1981 Aug; 24(8):1166-78. PubMed ID: 6272389
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Opioid antagonists in the periaqueductal gray inhibit morphine and beta-endorphin analgesia elicited from the amygdala of rats.
    Pavlovic ZW; Cooper ML; Bodnar RJ
    Brain Res; 1996 Nov; 741(1-2):13-26. PubMed ID: 9001699
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors.
    Pacheco Dda F; Romero TR; Duarte ID
    Brain Res; 2014 May; 1562():69-75. PubMed ID: 24675031
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Kappa-receptor antagonist reverse 'non-opioid' stress-induced analgesia.
    Panerai AE; Martini A; Sacerdote P; Mantegazza P
    Brain Res; 1984 Jun; 304(1):153-6. PubMed ID: 6331578
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Opioids in chronic pain.
    Przewłocki R; Przewłocka B
    Eur J Pharmacol; 2001 Oct; 429(1-3):79-91. PubMed ID: 11698029
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The contributions of mu-, delta- and kappa-opioid receptors to the actions of endogenous opioids on spinal reflexes in the rabbit.
    Clarke RW; Ford TW
    Br J Pharmacol; 1987 Jul; 91(3):579-89. PubMed ID: 3038245
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
    Freye E; Latasch L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antagonism of nitrous oxide antinociception in mice by intrathecally administered antisera to endogenous opioid peptides.
    Cahill FJ; Ellenberger EA; Mueller JL; Tseng LF; Quock RM
    J Biomed Sci; 2000; 7(4):299-303. PubMed ID: 10895052
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Analgesic nitrous oxide in neuropsychiatry: past, present and future.
    Gillman MA; Lichtigfeld FJ
    Int J Neurosci; 1989 Nov; 49(1-2):75-81. PubMed ID: 2691422
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.
    Beaudry H; Gendron L; Morón JA
    Eur J Neurosci; 2015 Apr; 41(7):901--7. PubMed ID: 25639561
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
    Comer SD; Burke TF; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1051-6. PubMed ID: 1326622
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Structure-activity relationship and pharmacology of the highly selective mu-opioid agonist, morphiceptin.
    Chang KJ
    NIDA Res Monogr; 1986; 69():101-11. PubMed ID: 3020411
    [No Abstract]   [Full Text] [Related]  

  • 76. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
    J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synergistic analgesic interactions between the periaqueductal gray and the locus coeruleus.
    Bodnar R; Paul D; Pasternak GW
    Brain Res; 1991 Sep; 558(2):224-30. PubMed ID: 1664270
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions.
    Chang HM; Berde CB; Holz GG; Steward GF; Kream RM
    Anesthesiology; 1989 Apr; 70(4):672-7. PubMed ID: 2467589
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Opioid receptors and acetaminophen (paracetamol).
    Raffa RB; Walker EA; Sterious SN
    Eur J Pharmacol; 2004 Oct; 503(1-3):209-10. PubMed ID: 15496316
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Potentiation of delta 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptors.
    Reche I; Fuentes JA; Ruiz-Gayo M
    Eur J Pharmacol; 1996 Dec; 318(1):11-6. PubMed ID: 9007506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.